s6y
Company name or ticker
Search
Omrix Biopharmaceuticals, Inc.
4
Burshtine Michael: Statement of changes in beneficial ownership of securities
Filed
Wednesday, January 9, 2008
Period
Jan 8, 2008
Accession number
0001209191-08-002718
Documents
FORM 4 SUBMISSION
4
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header